Sarcomatoid renal cell tumor harboring a novel BYSL::TFEB fusion with concurrent TFEB amplification

Overview of attention for article published in Genes, Chromosomes, and Cancer, February 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 11 X posts from 11 X users, with an upper bound of 18,801 followers.

RT @lili_PathMSH: Sarcomatoid renal cell tumor harboring a novel BYSL::TFEB fusion with concurrent TFEB amplification. PMID: 36704911 DOI:…

RT @lili_PathMSH: Sarcomatoid renal cell tumor harboring a novel BYSL::TFEB fusion with concurrent TFEB amplification. PMID: 36704911 DOI:…

RT @lili_PathMSH: Sarcomatoid renal cell tumor harboring a novel BYSL::TFEB fusion with concurrent TFEB amplification. PMID: 36704911 DOI:…

RT @lili_PathMSH: Sarcomatoid renal cell tumor harboring a novel BYSL::TFEB fusion with concurrent TFEB amplification. PMID: 36704911 DOI:…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.